Pertussis Vaccine Market Growth Accelerates: Strategic Forecast Predicts $6.62 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

What Will the Pertussis Vaccine Industry Market Size Be by 2025?
The market for the pertussis vaccine has experienced stable growth over the past few years. The market is expected to rise from $5.5 billion in 2024 to $5.72 billion in 2025, with a compound annual growth rate (CAGR) of 4.1%. The expansion during the historical period can be linked to factors such as the prevalence of the disease, vaccination campaigns, vaccine use in children, and approval from regulatory bodies.

What's the Long-Term Growth Forecast for the Pertussis Vaccine Market Size Through 2029?
In the ensuing years, a consistent increase in the size of the pertussis vaccine market is anticipated. The projection shows a growth of $6.62 billion by 2029, with a 3.7% compounded annual growth rate (CAGR). Factors contributing to this growth during the projected period may include booster vaccinations, maternity vaccinations, immunizations for healthcare staff, and worldwide health initiatives. Forecasts for the period take into account factors such as tailored immunization schedules, combined vaccines, vaccine equity programs, and the adoption of digital health for immunizations.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

What Are the Key Growth Drivers Fueling the Pertussis Vaccine Market Expansion?
Increased rates of childbirth are fuelling the expansion of the pertussis vaccine market. Giving birth, which signals the start of a new life outside the womb, is the final phase of pregnancy during which a fetus grows inside the mother's uterus. The pertussis vaccine, which is largely administered to children, safeguards them from whooping cough and other dangerous, possibly fatal diseases. As an example, a report released by the Centers for Disease Control and Prevention in January 2023 showed that registered births in the United States had risen by 1% from the previous year, reaching a total of 3,664,292. Hence, the surge in childbirth rates is propelling the growth of the pertussis vaccine market. In addition to this, the rise in geriatric population numbers is also expected to fuel the growth of the pertussis vaccine market. The term 'geriatric population' mainly refers to individuals aged 65 and above. The growing numbers of this demographic is a significant factor in the market for the pertussis vaccine. Due to longer lifespan, there is a higher demand for the pertussis vaccine as it shields older adults from this serious illness. As per the World Health Organization's data from October 2022, the global population aged 60 and above is expected to double by reaching 2.1 billion by 2050, while the population aged 80 years or more is predicted to triple reaching 426 million from 2020 to 2050. Therefore, the escalating geriatric population numbers are propelling the pertussis vaccine market's expansion.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13023&type=smp

What Are the Key Trends Driving Pertussis Vaccine Market Growth?
Leading businesses in the pertussis vaccine market are advancing through the development of novel drugs and obtaining needed approvals to hold their market position. For instance, in October 2022, GSK plc., a pharmaceutical and biotechnology firm based in the UK, declared that BOOSTRIX had received approval from the U.S. Food and Drug Administration (FDA). BOOSTRIX is a Tdap vaccine that combines tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed. It is administered during pregnancy to safeguard newborns against pertussis, also known as whooping cough. Only a single injection in the upper arm muscle is necessary. Boostrix has been shown to be safe and effective for expectant mothers and their infants while efficiently protecting against pertussis, including its severe cases.

How Is the Pertussis Vaccine Market Segmented?
The pertussis vaccine market covered in this report is segmented -

1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine
2) By Vaccine Type: Whole-Cell Vaccine, Acellular Vaccine
3) By Application: Children, Adults, Infants
4) By End-User: Vaccination Centers, Hospitals, Clinics

Subsegments:
1) By DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine: Pediatric DTaP Vaccine, Combination Vaccines With DTaP
2) By Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine: Adolescent Tdap Vaccine, Adult Tdap Vaccine

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13023&type=smp

Which Companies Are Leading the Charge in Pertussis Vaccine Market Innovation?
Major companies operating in the pertussis vaccine market are Pfizer Inc., Johnson And Johnson Pvt Ltd., Merck And Co. Inc., Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, BioNTech SE, Moderna Inc., Sinovac Biotech Ltd., CSL Limited, Astellas Pharma US Inc., Sanofi Pasteur SA, Mitsubishi Tanabe Pharma America Inc., PT Kalbe Farma Tbk, CSL Seqirus, Walvax Biotechnology Co.Ltd., Biological E. Limited, Serum Institute of India, Bavarian Nordic AS, PT Bio Farma, Bharat Biotech International Limited, Takeda Pharmaceutical Company, Panacea Biotec Limited, Beijing Minhai Biotechnology Co. Ltd., Protein Sciences Corporation, Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Gennova Biopharmaceuticals Ltd., Chiron Corporation.

Which Regions Are Leading the Global Pertussis Vaccine Market in Revenue?
North America was the largest region in the pertussis vaccine market in 2024. The regions covered in pertussis vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13023

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.